Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Enliven Therapeutics (ELVN)
NASDAQ:ELVN
RESEARCH TOOLSreports
Holding ELVN?
Track your performance easily
Enliven Therapeutics (ELVN) Ownership Overview
46.20% Insiders
15.35% Mutual Funds
1.18% Other Institutional Investors
9.50% ETFs
27.77% Public Companies and
Individual Investors
The ownership structure of Enliven Therapeutics (ELVN) stock is a mix of institutional, retail, and individual investors. Approximately 26.04% of the company’s stock is owned by Institutional Investors, 46.20% is owned by Insiders, and 27.77% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| May 20, 2024 | Orbimed Advisors Llc Director, >10% Owner | xxxxxxxxxxxxx | $22877262 |
| May 20, 2024 | Rishi Gupta Director, >10% Owner | xxxxxxxxxxxxx | $22877262 |
| Feb 16, 2024 | 5am Partners Vi, Llc >10% Owner | xxxxxxxxxxxxx | $12292500 |
| Feb 02, 2024 | 5am Partners Vi, Llc >10% Owner | xxxxxxxxxxxxx | $7500000 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Jun 30, 2024 | xxxxxxxxxxxxx | $5632 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $7505976 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $16884918 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,663,349 | Insider | 16.22% | 211,738,333 | |
| 7,663,349 | Insider | 16.22% | 211,738,333 | |
| 3,835,975 | Insider | 8.12% | 105,987,989 | |
| 3,202,798 | Institution | 6.78% | 88,493,309 | |
| 2,312,625 | Institution | 4.90% | 63,897,829 | |
| 2,122,465 | Institution | 4.49% | 58,643,708 | |
| 1,812,596 | Institution | 3.84% | 50,082,027 | |
| 1,652,807 | Institution | 3.50% | 45,667,057 | |
| 1,466,658 | Institution | 3.10% | 40,523,761 | |
| 1,015,188 | Insider | 2.15% | 28,049,644 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,652,807 | Institution | 3.50% | 45,667,057 | |
| 1,466,658 | Institution | 3.10% | 40,523,761 | |
| 979,038 | Institution | 2.07% | 27,050,820 | |
| 956,113 | Institution | 2.02% | 26,417,402 | |
| 513,246 | Institution | 1.09% | 14,180,987 | |
| 397,367 | Institution | 0.84% | 10,979,250 | |
| 322,550 | Institution | 0.68% | 8,912,057 | |
| 177,963 | Institution | 0.38% | 4,917,118 | |
| 160,470 | Institution | 0.34% | 4,433,786 | |
| 121,200 | Institution | 0.26% | 3,348,756 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,448,028 | Institution | 3.07% | 27,867,056 | |
| 962,754 | Institution | 2.04% | 26,600,893 | |
| 590,978 | Institution | 1.25% | 11,625,572 | |
| 298,161 | Institution | 0.63% | 8,238,188 | |
| 202,850 | Institution | 0.43% | 5,604,746 | |
| 160,977 | Institution | 0.34% | 4,111,353 | |
| 140,270 | Institution | 0.30% | 4,062,219 | |
| 80,350 | Institution | 0.17% | 2,220,071 | |
| 73,165 | Institution | 0.15% | 2,021,549 | |
| 62,801 | Institution | 0.13% | 1,603,938 |
FAQ
Who Owns Enliven Therapeutics (ELVN)?
According to the latest TipRanks data, approximately 1.18% of the company's stock is held by institutional investors, 46.20% is held by insiders, and 27.77% is held by retail investors.
What percentage of Enliven Therapeutics (ELVN) stock is held by institutional investors?
According to the latest TipRanks data, approximately 1.18% of Enliven Therapeutics (ELVN) stock is held by institutional investors.
What percentage of Enliven Therapeutics (ELVN) stock is held by retail investors?
According to the latest TipRanks data, approximately 27.77% of Enliven Therapeutics (ELVN) stock is held by retail investors.
Who owns the most shares of Enliven Therapeutics (ELVN)?
Rishi Gupta owns the most shares of Enliven Therapeutics (ELVN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.